Supernus Pharmaceuticals to Participate in June Investor Conferences Read more about Supernus Pharmaceuticals to Participate in June Investor Conferences
Supernus Pharmaceuticals to Participate in the Bank of America 2026 Health Care Conference Read more about Supernus Pharmaceuticals to Participate in the Bank of America 2026 Health Care Conference
Supernus Announces First Quarter 2026 Financial Results Read more about Supernus Announces First Quarter 2026 Financial Results
Supernus Pharmaceuticals to Announce First Quarter 2026 Financial Results and Host Conference Call on May 5, 2026 Read more about Supernus Pharmaceuticals to Announce First Quarter 2026 Financial Results and Host Conference Call on May 5, 2026
Supernus Announces Record Fourth Quarter and Full Year 2025 Financial Results Read more about Supernus Announces Record Fourth Quarter and Full Year 2025 Financial Results
Supernus Pharmaceuticals to Participate in March Investor Conferences Read more about Supernus Pharmaceuticals to Participate in March Investor Conferences
Supernus Pharmaceuticals to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on February 24, 2026 Read more about Supernus Pharmaceuticals to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on February 24, 2026
Supernus Pharmaceuticals to Participate in the Bank of America Securities 2025 CNS Therapeutics Virtual Conference Read more about Supernus Pharmaceuticals to Participate in the Bank of America Securities 2025 CNS Therapeutics Virtual Conference
Supernus Pharmaceuticals to Participate in the Piper Sandler 37th Annual Healthcare Conference Read more about Supernus Pharmaceuticals to Participate in the Piper Sandler 37th Annual Healthcare Conference
Supernus to Participate in the 2025 Jefferies Global Healthcare Conference in London Read more about Supernus to Participate in the 2025 Jefferies Global Healthcare Conference in London